Literature DB >> 20476679

[Post-operative analgesia in case of ano-rectal diseases].

Maurizio Rossitto1, Sebastiano Pantè, Antonino Manfrè, Antonio Ciccolo.   

Abstract

BACKGROUND: The aim of the study was that to evaluate the post-operative pain in case of ano-rectal diseases wether treated by ketorolac, or buprenorphine or tramadol.
MATERIALS AND METHODS: The intensity of post-operative pain was evaluated in 60 patients with hemorrhoidal diseases, fistulae, abscesses and anal neoplasms, divided into three homogenous groups and treated with intramuscular ketorolac (Group I), transdermal buprenorphine (Group II) and tramadol in elastomeric pump (Group III).
RESULTS: The average index of the visual analogue scale, as mean to evaluate the intensity of the post-operative pain, was 1,85 in the first group, 1,20 in the second one and 1,40 in the third group. DISCUSSION: In patients treated with transdermal buprenorphine or with tramadol in elastomeric pump there has been a more quick psycho-physical recovery than in those treated with ketorolac; the management of elastomeric pump represents however for patients cause of concern while the transdermal system is a kind of rational and comfortable way of treatment of the pain, with the advantage of being non-invasive.
CONCLUSIONS: Better compliance and lower operating costs have given the preference to the use of transdermal buprenorphine for the treatment of diseases of the post-operative pain in the diseases of the anal canal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20476679

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

Review 1.  Ketorolac for postoperative pain in children.

Authors:  Ewan D McNicol; Emily Rowe; Tess E Cooper
Journal:  Cochrane Database Syst Rev       Date:  2018-07-07

Review 2.  A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain.

Authors:  Cho Naing; Peng Nam Yeoh; Kyan Aung
Journal:  Springerplus       Date:  2014-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.